Oxygen treatment boosts the success of umbilical cord blood transplants

23 septiembre 2015

For the past 27 years, cord blood transplants have been a life-saving treatment option for thousands of people with leukemia, non-Hodgkins lymphoma, Hodgkins disease and myelodysplastic disorders. Cord blood helps replace cancerous blood cells and replenish a patient’s own bone marrow and immune system. Researchers have now completed a pilot clinical trial that tested the use of hyperbaric oxygen therapy to improve the outcomes of umbilical cord blood transplant patients, with positive results.